Comparison of in‐vivo and in‐silico methods used for prediction of tissue: plasma partition coefficients in rat

Objectives  To use methods from the literature to predict rat tissue:plasma partition coefficients (Kps) and volume of distribution values. Determine which model provides the most accurate predictions to increase confidence in the use of predicted pharmacokinetic parameters in physiologically based pharmacokinetic modelling.

[1]  Y. Sugiyama,et al.  Genetic polymorphisms of uptake (OATP1B1, 1B3) and efflux (MRP2, BCRP) transporters: implications for inter-individual differences in the pharmacokinetics and pharmacodynamics of statins and other clinically relevant drugs , 2009, Expert opinion on drug metabolism & toxicology.

[2]  L. Berezhkovskiy,et al.  Volume of distribution at steady state for a linear pharmacokinetic system with peripheral elimination. , 2004, Journal of pharmaceutical sciences.

[3]  K Krishnan,et al.  An algorithm for predicting tissue: blood partition coefficients of organic chemicals from n-octanol: water partition coefficient data. , 1995, Journal of toxicology and environmental health.

[4]  L. Berezhkovskiy,et al.  The influence of hepatic transport on the distribution volumes and mean residence time of drug in the body and the accuracy of estimating these parameters by the traditional pharmacokinetic calculations. , 2011, Journal of pharmaceutical sciences.

[5]  Malcolm Rowland,et al.  Lumping of Whole-Body Physiologically Based Pharmacokinetic Models , 1998, Journal of Pharmacokinetics and Biopharmaceutics.

[6]  F. Theil,et al.  A priori prediction of tissue:plasma partition coefficients of drugs to facilitate the use of physiologically-based pharmacokinetic models in drug discovery. , 2000, Journal of pharmaceutical sciences.

[7]  D. Cutler,et al.  The potential role of lysosomes in tissue distribution of weak bases , 1988, Biopharmaceutics & drug disposition.

[8]  Yuichi Sugiyama,et al.  In vitro-in vivo extrapolation of transporter-mediated clearance in the liver and kidney. , 2009, Drug metabolism and pharmacokinetics.

[9]  Mikko Niemi,et al.  Polymorphic Organic Anion Transporting Polypeptide 1B1 is a Major Determinant of Repaglinide Pharmacokinetics , 2005, Clinical pharmacology and therapeutics.

[10]  Walter Schmitt,et al.  General approach for the calculation of tissue to plasma partition coefficients. , 2008, Toxicology in vitro : an international journal published in association with BIBRA.

[11]  Patrick Poulin,et al.  Prediction of pharmacokinetics prior to in vivo studies. 1. Mechanism-based prediction of volume of distribution. , 2002, Journal of pharmaceutical sciences.

[12]  Patrick Poulin,et al.  Development of a novel method for predicting human volume of distribution at steady-state of basic drugs and comparative assessment with existing methods. , 2009, Journal of pharmaceutical sciences.

[13]  L. Aarons,et al.  Quantitative Structure–Pharmacokinetics Relationships: II. A Mechanistically Based Model to Evaluate the Relationship Between Tissue Distribution Parameters and Compound Lipophilicity , 1998, Journal of Pharmacokinetics and Biopharmaceutics.

[14]  H. B. Matthews,et al.  Using Structural Information to Create Physiologically Based Pharmacokinetic Models for All Polychlorinated Biphenyls: I. Tissue:Blood Partition Coefficients , 1997 .

[15]  M. Rowland,et al.  Physiologically based pharmacokinetic modeling 1: predicting the tissue distribution of moderate-to-strong bases. , 2005, Journal of pharmaceutical sciences.

[16]  Malcolm Rowland,et al.  Mechanistic Approaches to Volume of Distribution Predictions: Understanding the Processes , 2007, Pharmaceutical Research.

[17]  U. Bredberg,et al.  Prediction of drug tissue to plasma concentration ratios using a measured volume of distribution in combination with lipophilicity. , 2008, Journal of pharmaceutical sciences.

[18]  Walter Schmitt,et al.  Whole body physiologically-based pharmacokinetic models: their use in clinical drug development , 2008 .

[19]  M. Rowland,et al.  Physiologically based pharmacokinetic modelling 2: predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions. , 2006, Journal of pharmaceutical sciences.

[20]  M. Yamazaki,et al.  Tissue-selective uptake of pravastatin in rats: contribution of a specific carrier-mediated uptake system. , 1996, Biopharmaceutics & drug disposition.

[21]  F. Theil,et al.  Prediction of adipose tissue: plasma partition coefficients for structurally unrelated drugs. , 2001, Journal of pharmaceutical sciences.

[22]  S. Björkman.  Prediction of the volume of distribution of a drug: which tissue‐plasma partition coefficients are needed? , 2002, The Journal of pharmacy and pharmacology.

[23]  Kazuya Maeda,et al.  Physiologically Based Pharmacokinetic Modeling to Predict Transporter-Mediated Clearance and Distribution of Pravastatin in Humans , 2009, Journal of Pharmacology and Experimental Therapeutics.

[24]  Philip A. Arundel,et al.  A Multi-Compartmental Model Generally Applicable to Physiologically-Based Pharmacokinetics , 1997 .

[25]  Wilhelm Huisinga,et al.  Physiologically based pharmacokinetic modelling: a sub-compartmentalized model of tissue distribution , 2007, Journal of Pharmacokinetics and Pharmacodynamics.

[26]  Malcolm Rowland,et al.  Tissue distribution of basic drugs: accounting for enantiomeric, compound and regional differences amongst beta-blocking drugs in rat. , 2005, Journal of pharmaceutical sciences.

[27]  Malcolm Rowland,et al.  PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 2: comparative assessment of prediction methods of human volume of distribution. , 2011, Journal of pharmaceutical sciences.

[28]  J. Nedelman,et al.  Physiologically based pharmacokinetic modeling as a tool for drug development , 1995, Journal of pharmacokinetics and biopharmaceutics.

[29]  A. M. Cohen.  The disposition of ftorafur in rats after intravenous administration. , 1975, Drug metabolism and disposition: the biological fate of chemicals.

[30]  M. Taguchi,et al.  Pharmacokinetics and pharmacodynamics of bisoprolol in rats with bilateral ureter ligation-induced renal failure. , 2006, Drug metabolism and pharmacokinetics.

[31]  S. Mostafavi,et al.  PHARMACOKINETICS OF ACEBUTOLOL ENANTIOMERS AFTER INTRAVENOUS ADMINISTRATION OF RACEMATE IN A RAT MODEL: A DOSING RANGE COMPARISON , 1997, Biopharmaceutics & drug disposition.

[32]  U. Klotz.  Estimation of the blood-plasma concentration ratio of diazepam in the rat , 1985, Journal of Pharmacokinetics and Biopharmaceutics.

[33]  L. A. Fenu,et al.  Prediction of Human Pharmacokinetics Using Physiologically Based Modeling: A Retrospective Analysis of 26 Clinically Tested Drugs , 2007, Drug Metabolism and Disposition.

[34]  J Brian Houston,et al.  Saturable Uptake of Lipophilic Amine Drugs into Isolated Hepatocytes: Mechanisms and Consequences for Quantitative Clearance Prediction , 2007, Drug Metabolism and Disposition.

[35]  A. Leo,et al.  Partition coefficients and their uses , 1971 .

[36]  Ryosei Kawai,et al.  Physiologically based pharmacokinetic study on a cyclosporin derivative, SDZ IMM 125 , 1994, Journal of Pharmacokinetics and Biopharmaceutics.